West Pharmaceutical Services | WST - Des Atouts

Prix De L'Action
302.20
Variation Quotidienne
-3.96 -1.29%
Mensuellement
23.28%
Annuel
39.83%
Q2 Prévisions
299.61




Des Atouts Changement Date
Align Technology USD 6.23B 141K 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Cerus USD 215.18M 2.11M 2025-09
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dentsply International USD 5.43B 224M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
ICU Medical USD 4.05B 52.39M 2025-12
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Neogen USD 3.36B 953K 2025-12
OraSure Technologies USD 403.17M 19.93M 2025-12
Quidel USD 5.77B 94.2M 2025-12
Repligen USD 2.95B 25.99M 2025-12
Rockwell Medical USD 52.62M 1.34M 2025-06
Solventum Corp USD 14.29B 321M 2025-12
STAAR Surgical USD 451.68M 4.68M 2025-12
Terumo JPY 2.26T 362.12B 2025-12
Utah Medical Products USD 122.54M 567K 2025-12
West Pharmaceutical Services USD 4.11B 160.2M 2026-03